Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
Product Unit Size | Cost | Quantity | Stock |
---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
Cas No. | 1258595-14-0 |
---|---|
Purity | ≥99% |
Formula | C29H32F2N3O7P |
Formula Wt. | 603.56 |
IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
Synonym | LHC165 |
Appearance | Pale yellow powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Triterpene sapogenin found in species of Panax;...
Endogenous peptide hormone, GLP-1 fragment, inv...
Vitamin A metabolite, differentiation inducer; ...
Dibenzofuran produced by lichens.
Hormonal attractant for male Bactrocera flies.<...
Quaternary base alkaloid found in Phellodendron...
Smac mimetic; IAP inhibitor.
Peptide, used to tag proteins for affinity chro...
Prenylated phenolic terpene found in various pl...
Amide form of vitamin B3 required for productio...
Iron chelator.
Oxazolidinone; protein synthesis inhibitor.
α3β2, α3β4, α4β2 nAChR antagonist, indire...
KRAS inhibitor
Antimicrobial peptide.
5-HT3 antagonist.
Steroidal saponin found in Tribulus, Trigonella...
RT inhibitor.
Valsartan impurity
Calcium channel blocker.